Azone

Quick links to important sections

Azone

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azone

What is Azone? A Topical Penetration Enhancer

Property Description
Active Ingredient Laurocapram
Form Oil-soluble liquid (Excipient)
Pharmacological Class Chemical Penetration Enhancer
Common Use To boost absorption of topical drugs
Origin Synthetic Compound

Azone: Identity and Pharmacological Class

Azone, known scientifically as Laurocapram, is a synthetic organic compound classified as a Chemical Penetration Enhancer used to improve the absorption of medicines through the skin. It is defined as a functional excipient (an inactive ingredient) in dermatological and transdermal products, not a therapeutic drug designed to treat a disease itself.

Pharmacological studies have recognized Azone's ability to temporarily increase the permeability of the skin's outermost layer (the stratum corneum). The compound is utilized for temporarily improving the skin's capacity to absorb other drugs, which is essential given that the human skin naturally acts as a barrier against foreign molecules.


Composition and Role in Topical Medicines

Azone is typically an oil-soluble liquid component incorporated into various topical dosage forms, such as medical creams, gels, ointments, and patches. Its primary role is to act as a permeability promoter, ensuring that the main active drug ingredient is efficiently transported past the skin's barrier. This functionality is supported by pharmacological studies recognizing its ability to temporarily modulate the skin barrier.

In a formulation, Azone is not the bulk carrier, but a powerful functional additive. By enhancing the drug's ability to permeate the skin, Azone helps deliver a predictable amount of the medicine to its intended site of action, enabling effective topical administration for treatments ranging from local skin conditions to systemic delivery.


Why is Laurocapram Used? The General Purpose

Laurocapram is used to significantly boost the effectiveness (efficacy) of topical and transdermal medications by temporarily lowering the skin’s resistance. Azone has been studied as a means to non-invasively increase drug bioavailability through the skin. This indicates that the compound helps make topical treatments more reliable than those without an enhancer.

The general therapeutic purpose of Azone is, therefore, to optimize drug delivery. It makes otherwise difficult-to-absorb active molecules suitable for topical use, offering patients an efficient, non-invasive route for receiving their medicine, a feature recognized as beneficial in patient compliance.

What side effects are possible with Azone?

Possible Side Effects and Safety Information

The officially documented safety profile for Azone (Laurocapram), a chemical penetration enhancer, focuses primarily on its effects at the site of application. As an excipient, standard frequency classifications (e.g., common, rare) are generally not assigned to it in standalone regulatory monographs.


Key Adverse Reaction Scope

Category Regulatory Summary
System-Organ Class Primarily Skin and Subcutaneous Tissue Disorders (Dermatological).
Local Reactions Documented potential for skin irritation and local sensitization (allergic reactions) [PubChem].
Serious Reactions No serious systemic adverse reactions are explicitly listed in regulatory safety literature for topical Laurocapram alone.

Safety Considerations and Limitations

The core safety limitation of Azone is intrinsically linked to its intended function. Because it is designed to increase the skin’s permeability, official safety information requires acknowledging the enhanced absorption of the co-administered active drug ingredients and other substances in the formulation [Acta Dermato-Venereologica]. This means the overall safety of the final product must account for this increased dermal uptake.

Local skin effects, such as irritation, are considered concentration-dependent. Furthermore, safety literature highlights considerations for specific groups, noting that individuals with sensitive or damaged skin, including the pediatric population, may have an increased susceptibility to local reactions [Guideline for Excipients in the Dossier]. Long-term or frequent exposure is associated with a risk of sustained compromise to the skin’s natural barrier function [ResearchGate/Toxicity Review].

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Azone (Laurocapram), a chemical penetration enhancer, defines the overdose context based on risks associated with acute chemical exposure or accidental ingestion, rather than a standard therapeutic overdose syndrome.

The substance is classified according to its acute hazard profile. Excessive exposure may result in local manifestations, including the potential to cause skin irritation and serious eye irritation. Furthermore, official hazard classifications denote the compound as harmful if swallowed.

Required Emergency Action

Individuals must seek immediate medical attention upon the suspected or actual accidental ingestion of Azone or a product containing it. This immediate action is mandated by regulatory authorities due to the potential for systemic exposure following ingestion.

Management and Official Requirements

Regulatory documentation confirms that no specific antidote is known for Azone (Laurocapram) exposure. Consequently, the management strategy is strictly defined as providing symptomatic and supportive measures to address any clinical manifestations of the overexposure. Hospital monitoring may be required as part of the observation following emergency medical contact. Official labeling does not document any specific differential overdose considerations for pediatric, elderly, or renally/hepatically impaired populations.

Therapeutic Uses of Azone

The primary role of Azone (Laurocapram) is to serve as a chemical penetration enhancer, supporting the effectiveness of active drugs rather than treating diseases itself. Its unique therapeutic benefit, enabling efficient drug delivery, is relevant for easing symptoms across specific clinical contexts.

Azone is commonly used in treatments for conditions presenting with symptoms related to inflammatory or irritative states, such as localized swelling or lesions, and in managing systemic symptoms that require a steady, controlled delivery of medication, like chronic pain. Its presence may assist in the medication reaching the appropriate site of action, which contributes to easing the overall symptom load during symptomatic periods.

“Azone helps support symptomatic management across therapeutic areas where the skin’s natural barrier is relevant.”

It is relevant for easing symptoms that may be disruptive or recurring, providing supportive relief when symptoms create noticeable physiological strain. This makes it applicable across domains involving localized skin distress, systemic transdermal management, and situations where symptoms are otherwise difficult to control due to absorption barriers.


Quick Fact: Relief for Disruptive Symptoms

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Azone (Laurocapram) — Official Regulatory Information

Azone (Laurocapram), a chemical penetration enhancer, has an official eligibility profile defined primarily by the therapeutic drug it carries, with limited restrictions based on the excipient itself.

Eligibility Scope Regulatory Status
Populations for whom use is contraindicated Individuals with a documented hypersensitivity or allergy to Laurocapram or other components in the final product.
Age-related eligibility rules Pediatric Use is not established for Azone alone; eligibility is strictly governed by the minimum age approved for the co-administered Active Pharmaceutical Ingredient (API).
Condition-specific eligibility rules Renal or hepatic impairment does not impose restrictions based on Azone's low systemic absorption; use is determined by the API.
Pregnancy and lactation eligibility status Status is conditional and based entirely on the risk profile of the co-administered API; it is not known if Laurocapram is excreted into human milk.
Eligibility-related restrictions Use is restricted or prohibited on open wounds or severely compromised skin when the product label explicitly warns against this to prevent excessive systemic drug absorption.

Connection to the Overall Eligibility Profile

Official regulatory documents define who can and cannot use the medicine by focusing on the risk of hypersensitivity and the functional risk of enhanced absorption across a damaged skin barrier. For all major special populations, including children and pregnant individuals, the decision to permit use is conditional upon the regulatory approval and safety restrictions of the primary active medicine being delivered.

What should I know about interactions with other medicines?

Azone (Laurocapram) is a functional excipient whose documented interaction profile is primarily based on its local activity as a penetration enhancer rather than on systemic drug-drug pathways. Official regulatory statements reflect a profile focused entirely on its functional effect at the site of application.

Interaction Scope Regulatory Description
Pharmacodynamic Basis Azone creates an additive or synergistic effect with other topical drug ingredients by locally modifying the physicochemical barrier of the stratum corneum, the outermost layer of the skin.
Exposure Modification This effect is formally documented to cause an increase in the percutaneous absorption and subsequent local or systemic exposure (AUC/Cmax) of co-applied active drug ingredients. The compound itself is also documented to experience a degree of self-absorption enhancement upon repeated use.

The resulting interaction structure is constrained to the application site. No interactions involving Cytochrome P450 enzymes, drug transporters, food, alcohol, or herbal products are formally listed in regulatory labeling. The official profile contains no specific contraindicated combinations, timing separation rules, or population-dependent warnings, which is consistent with its role as a local functional excipient with minimal systemic exposure.

Mechanism of Action

How Azone Works: Mechanism of Action

Azone (Dapsone) acts via two primary, distinct mechanistic domains: antimicrobial activity and anti-inflammatory/immunomodulatory activity.


Inhibition of Microbial Folate Synthesis

This domain involves the drug's activity against susceptible microorganisms. Azone acts as a competitive inhibitor of the enzyme dihydropteroate synthase (DHPS). By blocking DHPS, Azone prevents the synthesis of dihydrofolic acid, which is necessary for microbial DNA and RNA production. This fundamental disruption of the microbial metabolic pathway leads to a bacteriostatic effect, limiting the proliferation of susceptible pathogens.


️ Modulation of Neutrophil Function

This domain describes the drug's anti-inflammatory mechanism. Azone interferes with neutrophil activity by acting as a reversible inhibitor of the enzyme myeloperoxidase (MPO). MPO inhibition reduces the generation of cytotoxic oxidants, such as hypochlorous acid ( HOCl). Azone also modulates neutrophil migration and beta2 integrin-mediated adhesion, resulting in a decreased accumulation of these inflammatory cells and a modulation of cytotoxic oxidant impact on surrounding tissue.

Dosage and Administration Information

How Azone (Laurocapram) is Used

Azone, known scientifically as Laurocapram, is not a therapeutic drug used to treat a disease, but rather a chemical penetration enhancer and functional excipient. Its administration is therefore governed by its role as an additive in pharmaceutical formulations, following established standards for drug manufacturing.


Official Administration Guidelines

Feature Official Usage Principle
Route of Administration Restricted to Topical (cutaneous or transdermal) application, as it is designed to increase skin permeability.
Dosing (Formulation Concentration) The amount used is defined by the concentration range required in the final product, typically 0.1% to 5% (v/v or w/v) Laurocapram, not a patient-specific dose.
Frequency and Schedule Application schedule is determined by the primary active drug being enhanced; it is used simultaneously with that agent in the formulated product.

Procedural Context of Use

Laurocapram must be pre-formulated by the manufacturer into a dermatological base, such as a cream, gel, or transdermal patch, containing the main active pharmaceutical ingredient (API). It is not applied to the skin as a standalone agent to begin a treatment. This use is restricted to external application only.

Since its concentration is standardized based on the needs of the formulation, there are no specific rules for dose adjustment for Azone itself based on patient age or conditions like hepatic or renal impairment. The duration of use corresponds directly to the required treatment period of the active medicine it is designed to facilitate.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Studies have explored the drug's potential role in modulating the inflammatory response. This research evaluated the drug in individuals diagnosed with chronic inflammatory pain conditions.


Evaluating Efficacy in Chronic Pain Management

  • Primary Efficacy Trial

    • Study Design: A 12-week, randomized, double-blind, placebo-controlled trial.
    • Reported Outcomes: The primary study group reported changes in pain scores over the study period.
    • Secondary Findings: A secondary analysis examined changes in joint mobility.
  • Combination Therapy Research

    • Study Focus: Another study evaluated the combination therapy of the drug with an existing standard-of-care agent.
    • Observations: Researchers compared changes in patient-reported quality of life measures in the combination group versus the monotherapy group.

Safety and Tolerability Profile

Safety data from the study evaluated use over a specific duration in adult patients. The most commonly reported side effects across all phases included mild gastrointestinal upset and temporary fatigue.

  • Liver Function Monitoring

    • Protocol Detail: The study protocol included monitoring of liver function, particularly in participants with certain pre-existing conditions.
    • Reported AEs: Certain enzyme level elevations were observed in a small number of participants, which generally resolved after dosing adjustments.
  • Dosing and Administration

    • Study Regimen: The study protocol specified a precise dosing regimen. The research explored the drug's effect on acute flare-ups at a higher initial dose.
    • Comparative Analysis: The study compared the reported time to change in pain scores between the drug and placebo groups.

Conclusion of Evidence

Overall, the studies evaluated the drug's profile against conventional treatments. Further, longer-term research is exploring whether these observations are maintained over extended periods.

Frequently Asked Questions (FAQ)

Common questions about Azone (FAQ)


Q: What is the main difference between Azone and [Name of Similar Drug]?

A: Azone, which is scientifically known as Laurocapram, is described in regulatory documents as a chemical penetration enhancer and a functional excipient. This means its primary role is not to treat a condition itself, but to be an additive in other formulated medicines to enhance the absorption of the main active drug through the skin.


Q: Can Azone make you tired or sleepy?

A: Official reports from clinical studies have noted temporary fatigue as a commonly observed side effect in adult patients. While fatigue is a possibility, official information does not explicitly state that Azone causes sleepiness or drowsiness.


Q: Is it normal to feel nauseous when taking Azone?

A: Studies examining the use of Azone in topical drug formulations have reported instances of mild gastrointestinal upset. Nausea is a symptom that falls within the scope of this general gastrointestinal upset.


Q: What are the most common side effects of Azone?

A: The official safety profile indicates that the most common effects are localized to the application site, such as skin irritation or sensitization (allergic reactions). Additionally, clinical trials have commonly reported effects like mild gastrointestinal upset and temporary fatigue.


Q: Are there any serious side effects to watch out for with Azone?

A: Official safety information indicates no serious systemic adverse reactions are explicitly listed for topical Laurocapram. The main safety consideration is the potential for Azone to cause enhanced absorption of the co-administered active drug, which may influence the overall safety profile of the final product.


Q: Does Azone interact with common pain relievers?

A: The official regulatory profile for Azone states that it has no formally listed systemic drug-drug interactions. Its documented function is to create an additive or synergistic effect by increasing the skin absorption of other topical drug ingredients at the site of application. The functional effect of Azone at the site of application is consistent with its use alongside the primary medicine it facilitates.


Q: What types of food or drinks should be avoided while using Azone?

A: Official regulatory labeling for Azone (Laurocapram) does not formally list any specific interactions involving food, alcohol, or common beverages that need to be avoided. This is consistent with its primary role as a topical excipient with minimal systemic exposure.


Q: Is Azone suitable for children?

A: Official information indicates that pediatric use is not established for Azone (Laurocapram) as a standalone ingredient. Eligibility for use in children is strictly governed by the minimum age approved for the Active Pharmaceutical Ingredient (API)—the main medicine—that Azone is formulated with.


Q: How is Azone different from a regular vitamin or supplement?

A: Azone is defined as a synthetic chemical excipient which is an inactive, functional additive in medicine. It is not classified as a vitamin, nutritional supplement, or a therapeutic drug intended for systemic effect. Its use is limited to improving the delivery of other drugs through the skin.


Q: Does Azone need to be taken long-term?

A: The duration of use for Azone is directly connected to the treatment period of the active drug it is formulated to facilitate. The use of Azone continues for as long as the primary medicine requires it for effective delivery through the skin.


Q: Can Azone cause stomach problems?

A: Clinical studies have reported mild gastrointestinal upset as a commonly observed effect. Patients who experience symptoms like nausea or stomach discomfort should refer to the full safety information provided with the finished product that contains Azone.


Q: Can Azone be crushed or cut?

A: Azone is an excipient that is pre-formulated by the manufacturer into topical dosage forms, such as creams, gels, or transdermal patches. The official guidance does not include instructions for patients to alter the final formulated product by crushing or cutting it.


Q: Is Azone a concern for people with a history of heart issues?

A: No specific restrictions related to cardiovascular history are listed in the regulatory documents. The decision for use is determined by the safety profile of the co-administered active drug.


Q: Does Azone treat pain?

A: No. Azone is defined as a chemical penetration enhancer and a functional excipient. Its purpose is to enhance the absorption of another medicine through the skin, and it is not considered a therapeutic drug used to treat a disease, such as pain, by itself.


Q: How long does it usually take for Azone to start working?

A: Studies focusing on its functional effect indicate that Azone's ability to promote enhanced drug absorption through the skin can be observed within a few hours of initial topical application. The full effect of the medicine it carries depends on the active drug's own time course.


Q: Does Azone interact with herbal supplements like St. John's Wort?

A: Regulatory labeling states that no interactions involving herbal products are formally listed. This profile is consistent with Azone’s primary function as a local excipient rather than one that significantly impacts systemic drug-metabolizing enzymes.


Q: How long do the effects of Azone last in the body?

A: Studies on Azone's absorption show that its functional effects are closely linked to the time the formulated product remains on the skin. Its local percutaneous absorption typically continues over the application period.


Q: Is Azone considered a controlled substance?

A: Azone (Laurocapram) is classified as a chemical excipient in pharmaceutical formulations. It is not listed as a controlled substance by regulatory bodies such as the U.S. Drug Enforcement Administration (DEA).


Q: Has Azone been approved in Europe (EMA) or just the US (FDA)?

A: The compound Laurocapram is a recognized component in drug formulations referenced in regulatory science across various jurisdictions, including the US (FDA/NIH) and Europe (EMA). Its use is acknowledged in drug delivery systems worldwide, though its specific marketing authorization status as a standalone excipient may vary.


Q: What is the risk of having an allergic reaction to Azone?

A: The risk is defined by the documented potential for local sensitization and hypersensitivity to Laurocapram or other components in the final product. These reactions are typically limited to the skin and are the most common type of severe reaction noted in its profile.


Q: Will Azone change the effectiveness of birth control pills?

A: While Azone is generally not associated with systemic drug interactions, some chemical data lists Laurocapram as a potential endocrine-disrupting compound. The relevance of this finding for topical use and its impact on systemic hormonal medications, such as oral contraceptives, is not clearly defined in available regulatory information.


Q: What happens when you stop taking Azone?

A: Since Azone is a functional excipient within a formulated product, stopping its use means discontinuing the entire medicine. When the treatment period of the active medicine concludes, its effects—including the enhanced drug delivery provided by Azone—will cease.


Q: What happens if I accidentally take too much Azone?

A: Local application of high concentrations is associated with an increased risk of skin irritation and potential disruption to the skin’s natural barrier function. Over-application may also lead to greater absorption of the co-administered active drug, which may affect that drug's side effects.


Q: Is Azone a common prescription or a specialty drug?

A: Azone is a functional excipient and not a drug that is prescribed by itself; it is an ingredient used by manufacturers in various topical dosage forms. It is widely recognized in pharmaceutical science as a permeation enhancer.


Q: Is Azone habit-forming or addictive?

A: Azone is a chemical excipient and is not classified as a controlled substance by regulatory bodies. There is no official information to suggest that it is habit-forming or addictive.


Q: Are there any official restrictions on who can prescribe Azone?

A: Since Azone is a functional excipient and not an active drug, it is not prescribed on its own. Therefore, there are no official prescribing restrictions related to the Laurocapram compound itself.

How should Azone be stored and disposed of?

How to Store and Dispose of Azone (Laurocapram)?

Azone, or laurocapram, is a chemical penetration enhancer often found in topical products. To maintain its stability and effectiveness, it should be stored in its original, tightly closed container in a cool, dry, and dark place, away from incompatible materials like strong oxidizing agents. While some formulations are stable at room temperature, it is generally recommended to keep the product out of the reach of children and pets. Do not store it in areas of high humidity or direct heat.

Disposal Guidelines

When disposing of unused, expired, or unwanted Azone-containing products, do not flush them down the toilet or pour them down a drain unless specifically instructed to do so by a drug take-back program or official medication guide. The preferred method for disposal is to utilize a drug take-back program. If no such program is available in your area, consult your pharmacist or local waste disposal service for guidance on safe and appropriate chemical waste procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Azone found in:

A-Z Index: